Related Experiment Video
Updated: May 5, 2026

10:30
Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
Published on: December 8, 2016
10.4K
Extracellular Vesicles in Osteogenesis: Comparative Analysis of Stem Cell Sources, Conditioning Strategies, and In
Luca Dalle Carbonare1, Arianna Minoia1, Michele Braggio2
1Department of Engineering for the Innovation Medicine, University of Verona, 37100 Verona, Italy.
Cells
|January 9, 2026
Summary
Stem cell-derived extracellular vesicles (EVs) show promise for bone regeneration. This review analyzes EV sources, conditioning methods, and models, highlighting challenges and future directions for cell-free bone therapies.
Area of Science:
- Regenerative Medicine
- Biotechnology
- Tissue Engineering
Background:
- Stem cell-derived extracellular vesicles (EVs) are key mediators of osteogenesis.
- They offer potential cell-free therapeutic alternatives for bone regeneration.
- Diverse stem cell sources (e.g., BM-MSCs, ADSCs, UC-MSCs, iPSCs) are utilized for EV production.
Purpose of the Study:
- To comprehensively review stem cell sources for EV production in bone regeneration.
- To analyze how conditioning strategies modulate EV cargo and therapeutic potential.
- To discuss in vitro models for evaluating EV-mediated bone regeneration and outline future directions.
Main Methods:
- Comparative analysis of EVs from various stem cell sources (BM-MSCs, ADSCs, UC-MSCs, iPSCs).
- Evaluation of conditioning strategies (osteogenic induction, hypoxia, mechanical stimulation) on EV properties.
- Review of in vitro models including 2D cultures, 3D spheroids, scaffolds, and bone organoids.
Main Results:
- Different stem cell sources and conditioning methods significantly impact EV cargo and osteogenic potential.
- Advanced in vitro models are crucial for assessing EV efficacy in bone regeneration.
- Standardization, scalable production, and clinical translation remain significant challenges.
Conclusions:
- Stem cell-derived EVs represent a promising cell-free approach for bone tissue engineering.
- Future research should focus on bioengineering, advanced models, and multi-omics integration for optimized therapies.
- An integrated framework combining EV source analysis, engineering strategies, and clinical perspectives is needed for translational success.
Related Concept Videos
Mesenchymal Stem Cells
4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K
Stem Cell Therapy for Tissue Regeneration
3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K

